semaglutide patents Semaglutide's patent expires today. What does it mean for patients, pharma players and Novo Nordisk? Massive Rs 50,000 Cr Opportunity

Advanced Facility We use cutting-edge medical technology to address aging-factors in your health

Topical research formulations commonly reference GHK-Cu concentrations in the range of 0.05% to 2%, with research formulations frequently using 1-2% for skin regeneration research and lower concentrations for sensitive-area research

Common Mistakes to Avoid When a new medication shows this much promise, it is easy to get swept up in the hype

What Happens When You Stop Semaglutide Semaglutide belongs to a class of medications called GLP-1 receptor agonists, which work by slowing digestion, increasing feelings of fullness, and helping the body release insulin more efficiently

Claims of specific fat-loss percentages are not well supported, so treat them with caution

The landscape continues evolving